INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia

NCT00697658 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone ER

Sponsor

Janssen-Cilag B.V.